KCNA3 and metabolic disease: Due to this unique combination of physiological effects driven by Kv1.3, the channel has become an important and promising therapeutic target for neuroinflammatory diseases, metabolic disorders, and neurodegeneration (Pérez‐Verdaguer et al. 2016; Serrano‐Albarras et al. 2018).